Brazil · Delayed Price · Currency is BRL Raia Drogasil Statistics
Total Valuation
Raia Drogasil has a market cap or net worth of BRL 25.86 billion. The enterprise value is 34.07 billion.
| Market Cap | 25.86B |
| Enterprise Value | 34.07B |
Important Dates
The last earnings date was Tuesday, November 3, 2026.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | Oct 8, 2026 |
Share Statistics
Raia Drogasil has 1.75 billion shares outstanding. The number of shares has decreased by -2.88% in one year.
| Current Share Class | 1.75B |
| Shares Outstanding | 1.75B |
| Shares Change (YoY) | -2.88% |
| Shares Change (QoQ) | -0.34% |
| Owned by Insiders (%) | 18.82% |
| Owned by Institutions (%) | 47.58% |
| Float | 1.30B |
Valuation Ratios
The trailing PE ratio is 18.71 and the forward PE ratio is 13.12. Raia Drogasil's PEG ratio is 0.60.
| PE Ratio | 18.71 |
| Forward PE | 13.12 |
| PS Ratio | 0.55 |
| PB Ratio | 3.42 |
| P/TBV Ratio | 4.72 |
| P/FCF Ratio | 26.80 |
| P/OCF Ratio | 10.58 |
| PEG Ratio | 0.60 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.96, with an EV/FCF ratio of 35.31.
| EV / Earnings | 26.27 |
| EV / Sales | 0.72 |
| EV / EBITDA | 6.96 |
| EV / EBIT | 11.74 |
| EV / FCF | 35.31 |
Financial Position
The company has a current ratio of 1.40, with a Debt / Equity ratio of 1.17.
| Current Ratio | 1.40 |
| Quick Ratio | 0.47 |
| Debt / Equity | 1.17 |
| Debt / EBITDA | 1.81 |
| Debt / FCF | 9.15 |
| Interest Coverage | 2.46 |
Financial Efficiency
Return on equity (ROE) is 19.72% and return on invested capital (ROIC) is 16.69%.
| Return on Equity (ROE) | 19.72% |
| Return on Assets (ROA) | 7.33% |
| Return on Invested Capital (ROIC) | 16.69% |
| Return on Capital Employed (ROCE) | 19.16% |
| Weighted Average Cost of Capital (WACC) | 6.53% |
| Revenue Per Employee | 611,696 |
| Profits Per Employee | 16,747 |
| Employee Count | 77,428 |
| Asset Turnover | 1.92 |
| Inventory Turnover | 3.84 |
Taxes
In the past 12 months, Raia Drogasil has paid 175.25 million in taxes.
| Income Tax | 175.25M |
| Effective Tax Rate | 10.88% |
Stock Price Statistics
The stock price has decreased by -29.83% in the last 52 weeks. The beta is 0.08, so Raia Drogasil's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | -29.83% |
| 50-Day Moving Average | 19.06 |
| 200-Day Moving Average | 20.53 |
| Relative Strength Index (RSI) | 30.07 |
| Average Volume (20 Days) | 15,704,230 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Raia Drogasil had revenue of BRL 47.36 billion and earned 1.30 billion in profits. Earnings per share was 0.79.
| Revenue | 47.36B |
| Gross Profit | 14.64B |
| Operating Income | 2.90B |
| Pretax Income | 1.61B |
| Net Income | 1.30B |
| EBITDA | 3.81B |
| EBIT | 2.90B |
| Earnings Per Share (EPS) | 0.79 |
Balance Sheet
The company has 627.20 million in cash and 8.83 billion in debt, with a net cash position of -8.21 billion or -4.69 per share.
| Cash & Cash Equivalents | 627.20M |
| Total Debt | 8.83B |
| Net Cash | -8.21B |
| Net Cash Per Share | -4.69 |
| Equity (Book Value) | 7.55B |
| Book Value Per Share | 4.32 |
| Working Capital | 4.16B |
Cash Flow
In the last 12 months, operating cash flow was 2.44 billion and capital expenditures -1.48 billion, giving a free cash flow of 964.86 million.
| Operating Cash Flow | 2.44B |
| Capital Expenditures | -1.48B |
| Depreciation & Amortization | 906.54M |
| Net Borrowing | -783.85M |
| Free Cash Flow | 964.86M |
| FCF Per Share | 0.55 |
Margins
Gross margin is 30.91%, with operating and profit margins of 6.13% and 2.74%.
| Gross Margin | 30.91% |
| Operating Margin | 6.13% |
| Pretax Margin | 3.40% |
| Profit Margin | 2.74% |
| EBITDA Margin | 8.04% |
| EBIT Margin | 6.13% |
| FCF Margin | 2.04% |
Dividends & Yields
This stock pays an annual dividend of 0.39, which amounts to a dividend yield of 2.65%.
| Dividend Per Share | 0.39 |
| Dividend Yield | 2.65% |
| Dividend Growth (YoY) | 27.33% |
| Years of Dividend Growth | 12 |
| Payout Ratio | 26.57% |
| FCF Payout Ratio | 81.66% |
| Buyback Yield | 2.88% |
| Shareholder Yield | 5.53% |
| Earnings Yield | 5.34% |
| FCF Yield | 3.73% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for Raia Drogasil is 24.00, which is 62.27% higher than the current price. The consensus rating is "Buy".
| Price Target | 24.00 |
| Price Target Difference | 62.27% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | 9.14% |
| EPS Growth Forecast (3Y) | 19.47% |
Stock Splits
The last stock split was on December 23, 2025. It was a forward split with a ratio of 1.02.
| Last Split Date | Dec 23, 2025 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
Raia Drogasil has an Altman Z-Score of 3.78 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.78 |
| Piotroski F-Score | 7 |